70
Views
7
CrossRef citations to date
0
Altmetric
Review

Update on the challenges and recent advances in cancer immunotherapy

, , , , , & show all
Pages 39-49 | Published online: 17 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Manu Smriti Singh & Sangeeta Bhaskar. (2014) Nanocarrier-based immunotherapy in cancer management and research. ImmunoTargets and Therapy 3, pages 121-134.
Read now

Articles from other publishers (6)

Xueqing Sui, Teng Jin, Tonghui Liu, Shiman Wu, Yue Wu, Zhongmin Tang, Yan Ren, Dalong Ni, Zhenwei Yao & Hua Zhang. (2020) Tumor Immune Microenvironments (TIMEs): Responsive Nanoplatforms for Antitumor Immunotherapy. Frontiers in Chemistry 8.
Crossref
Qiushuang Li, Yang Xiong, Conghua Ji & Zhiqiang Yan. (2019) The Application of Nanotechnology in the Codelivery of Active Constituents of Plants and Chemotherapeutics for Overcoming Physiological Barriers during Antitumor Treatment. BioMed Research International 2019, pages 1-16.
Crossref
Vu Luan Dang Chi, Soizic Garaud, Pushpamali De Silva, Vincent Thibaud, Basile Stamatopoulos, Mimoune Berehad, Chunyan Gu-Trantien, Mohammad Krayem, Hugues Duvillier, Jean-Nicolas Lodewyckx, Karen Willard-Gallo, Catherine Sibille & Dominique Bron. (2019) Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients. BMC Cancer 19:1.
Crossref
Yasen Maimaitiyiming, De Fei Hong, Chang Yang & Hua Naranmandura. (2019) Novel insights into the role of aptamers in the fight against cancer. Journal of Cancer Research and Clinical Oncology 145:4, pages 797-810.
Crossref
Xiaoling Gao, Lihua Guo, Jianqiang Li, Hnin Ei Thu & Zahid Hussain. (2018) Nanomedicines guided nanoimaging probes and nanotherapeutics for early detection of lung cancer and abolishing pulmonary metastasis: Critical appraisal of newer developments and challenges to clinical transition. Journal of Controlled Release 292, pages 29-57.
Crossref
Ayed O. Ayed, Lung-Ji Chang & Jan S. Moreb. (2015) Immunotherapy for multiple myeloma: Current status and future directions. Critical Reviews in Oncology/Hematology 96:3, pages 399-412.
Crossref